GB2478441B - Lung cancer biomarkers and uses thereof - Google Patents

Lung cancer biomarkers and uses thereof

Info

Publication number
GB2478441B
GB2478441B GB1106053.0A GB201106053A GB2478441B GB 2478441 B GB2478441 B GB 2478441B GB 201106053 A GB201106053 A GB 201106053A GB 2478441 B GB2478441 B GB 2478441B
Authority
GB
United Kingdom
Prior art keywords
lung cancer
cancer biomarkers
biomarkers
lung
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1106053.0A
Other languages
English (en)
Other versions
GB201106053D0 (en
GB2478441A (en
Inventor
Larry Gold
Marty Stanton
Edward N Brody
Rachel M Ostroff
Dominic Zichi
Alex A E Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somalogic Inc
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of GB201106053D0 publication Critical patent/GB201106053D0/en
Publication of GB2478441A publication Critical patent/GB2478441A/en
Application granted granted Critical
Publication of GB2478441B publication Critical patent/GB2478441B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Algebra (AREA)
  • Software Systems (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Databases & Information Systems (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Analysis (AREA)
GB1106053.0A 2008-09-09 2009-09-09 Lung cancer biomarkers and uses thereof Active GB2478441B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9559308P 2008-09-09 2008-09-09
US15283709P 2009-02-16 2009-02-16
PCT/US2009/056399 WO2010030697A1 (en) 2008-09-09 2009-09-09 Lung cancer biomarkers and uses thereof

Publications (3)

Publication Number Publication Date
GB201106053D0 GB201106053D0 (en) 2011-05-25
GB2478441A GB2478441A (en) 2011-09-07
GB2478441B true GB2478441B (en) 2013-03-27

Family

ID=42005456

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1106053.0A Active GB2478441B (en) 2008-09-09 2009-09-09 Lung cancer biomarkers and uses thereof

Country Status (14)

Country Link
EP (1) EP2340506B1 (cg-RX-API-DMAC7.html)
JP (1) JP5701212B2 (cg-RX-API-DMAC7.html)
KR (1) KR101658347B1 (cg-RX-API-DMAC7.html)
CN (2) CN102209968B (cg-RX-API-DMAC7.html)
AU (2) AU2009291811B2 (cg-RX-API-DMAC7.html)
CA (3) CA3152591C (cg-RX-API-DMAC7.html)
DK (1) DK2340506T3 (cg-RX-API-DMAC7.html)
ES (1) ES2559758T3 (cg-RX-API-DMAC7.html)
GB (1) GB2478441B (cg-RX-API-DMAC7.html)
HK (1) HK1204062A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20160127T1 (cg-RX-API-DMAC7.html)
MX (1) MX2011002322A (cg-RX-API-DMAC7.html)
SI (1) SI2340506T1 (cg-RX-API-DMAC7.html)
WO (1) WO2010030697A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
JP2012520469A (ja) 2009-03-12 2012-09-06 キャンサー・プリヴェンション・アンド・キュア，リミテッド 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
US20130116150A1 (en) 2010-07-09 2013-05-09 Somalogic, Inc. Lung Cancer Biomarkers and Uses Thereof
KR101857462B1 (ko) 2010-08-13 2018-05-14 소마로직, 인크. 췌장암 바이오마커 및 그것의 용도
CA2832480C (en) * 2011-04-07 2022-05-31 The Scripps Research Institute High-throughput screening for compounds modulating expression of cellular macromolecules
EP2702411A4 (en) * 2011-04-29 2015-07-22 Cancer Prevention & Cure Ltd METHOD FOR IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREFOR
EP2771692B1 (en) * 2011-10-24 2018-04-18 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
AU2012358246B2 (en) 2011-12-21 2018-01-25 Integrated Diagnostics, Inc. Methods for diagnosis of lung cancer
CN104115150B (zh) * 2012-02-17 2018-05-04 皇家飞利浦有限公司 急性肺损伤(ali)/急性呼吸窘迫整合征(ards)评估和监测
WO2014074682A1 (en) 2012-11-07 2014-05-15 Somalogic, Inc. Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof
KR102310799B1 (ko) * 2013-11-07 2021-10-12 미디얼 리서치 리미티드 폐암 위험 평가 방법 및 시스템
KR102087373B1 (ko) * 2015-09-11 2020-03-10 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
FR3050269B1 (fr) * 2016-04-15 2018-05-11 Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) Procede de selection et de recuperation de produits et systeme associe
CN105823665A (zh) * 2016-05-13 2016-08-03 北京九州柏林生物科技有限公司 生物组织样本制备套液
KR20190026769A (ko) 2016-06-21 2019-03-13 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 유전자 발현 프로파일을 사용하여 폐암을 진단하기 위한 조성물 및 방법
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
WO2018187496A2 (en) 2017-04-04 2018-10-11 Lung Cancer Proteomics, Llc Plasma based protein profiling for early stage lung cancer prognosis
EP3676393A4 (en) 2017-09-01 2021-10-13 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND MONITORING OF TREATMENT
CN111630602A (zh) * 2017-11-22 2020-09-04 磨石肿瘤生物技术公司 减少新抗原的接合表位呈递
JP2021506308A (ja) 2017-12-19 2021-02-22 ザ・ウイスター・インステイテユート・オブ・アナトミー・アンド・バイオロジー 遺伝子発現プロファイルを使用して肺癌を診断するための組成物および方法
CN112638845B (zh) * 2018-06-22 2024-07-30 私募蛋白质体运营有限公司 改进的蛋白质组学多重测定
US20220397575A1 (en) * 2019-06-21 2022-12-15 National University Of Singapore Methods for determining the likelihood of lung cancer
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
CN111047609B (zh) * 2020-03-13 2020-07-24 北京深睿博联科技有限责任公司 肺炎病灶分割方法和装置
CN113960235B (zh) * 2020-10-10 2023-03-14 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 生物标志物在制备肺癌检测试剂中的用途和方法
CN112557514B (zh) * 2020-12-22 2021-09-21 中国海洋大学 手持式海底沉积物样品剖面声学全自动测量装置
WO2025137139A1 (en) * 2023-12-18 2025-06-26 Caris Mpi, Inc. Dynamic tissue typing

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002073204A2 (en) * 2001-03-12 2002-09-19 Monogen, Inc Cell-based detection and differentiation of disease states
US20050260697A1 (en) * 2004-04-15 2005-11-24 University Of Florida Research Foundation, Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
WO2006022895A2 (en) * 2004-08-02 2006-03-02 Children's Medical Center Corporation Platelet biomarkers for cancer
US20060223127A1 (en) * 2002-12-18 2006-10-05 Ciphergen Biosystems, Inc. Serum biomarkers in lung cancer
US20070178504A1 (en) * 2005-12-22 2007-08-02 Tracey Colpitts Methods and marker combinations for screening for predisposition to lung cancer
WO2011031344A1 (en) * 2009-09-09 2011-03-17 Somalogic, Inc. Cancer biomarkers and uses thereof
WO2011100483A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary biomarkers for lung cancer detection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
EP1463928A2 (en) * 2001-04-18 2004-10-06 Protein Design Labs Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
CN1225477C (zh) * 2003-03-28 2005-11-02 上海市疾病预防控制中心 肺癌早期血清特异蛋白及其应用
CN1455257A (zh) * 2003-05-23 2003-11-12 北京师范大学 一种利用表面修饰蛋白芯片进行肺癌诊断方法
ES2360073T3 (es) * 2004-03-23 2011-05-31 Oncotherapy Science, Inc. Método para diagnosticar cáncer de pulmón de células no pequeñas.
JP2005304497A (ja) * 2004-03-25 2005-11-04 Joji Inasawa 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法
WO2005103281A2 (en) * 2004-04-26 2005-11-03 Children's Medical Center Corporation Platelet biomarkers for the detection of disease
CN1873417A (zh) * 2005-06-02 2006-12-06 中国医学科学院肿瘤医院肿瘤研究所 一种用于诊断肺癌的蛋白质芯片
US7908091B2 (en) * 2006-03-17 2011-03-15 Prometheus Laboratories Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
US20080195327A1 (en) * 2006-10-17 2008-08-14 Synergenz Bioscience Limited Methods of Analysis of Polymorphisms and Uses Thereof
US20110119776A1 (en) * 2007-02-05 2011-05-19 Wong Kwok-Kin Methods of diagnosing and prognosing lung cancer
KR100846354B1 (ko) * 2007-03-21 2008-07-15 (주) 프로탄바이오 혈청 당단백질부터 분리한 폐암 진단용 마커
US20100184773A1 (en) * 2007-05-18 2010-07-22 Heinz-Josef Lenz Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer Therapy
WO2009036123A1 (en) * 2007-09-11 2009-03-19 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
WO2010003772A1 (en) * 2008-06-16 2010-01-14 Siemens Medical Solutions Diagnostics Gmbh Method for predicting adverse response to erythropoietin in breast cancer treatment

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002073204A2 (en) * 2001-03-12 2002-09-19 Monogen, Inc Cell-based detection and differentiation of disease states
US20060223127A1 (en) * 2002-12-18 2006-10-05 Ciphergen Biosystems, Inc. Serum biomarkers in lung cancer
US20050260697A1 (en) * 2004-04-15 2005-11-24 University Of Florida Research Foundation, Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
WO2006022895A2 (en) * 2004-08-02 2006-03-02 Children's Medical Center Corporation Platelet biomarkers for cancer
US20070178504A1 (en) * 2005-12-22 2007-08-02 Tracey Colpitts Methods and marker combinations for screening for predisposition to lung cancer
WO2011031344A1 (en) * 2009-09-09 2011-03-17 Somalogic, Inc. Cancer biomarkers and uses thereof
WO2011100483A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary biomarkers for lung cancer detection

Also Published As

Publication number Publication date
GB201106053D0 (en) 2011-05-25
KR101658347B1 (ko) 2016-09-21
AU2015249113B2 (en) 2017-09-07
CA3011730A1 (en) 2010-03-18
CA3152591C (en) 2023-08-29
WO2010030697A1 (en) 2010-03-18
MX2011002322A (es) 2011-05-10
HK1204062A1 (zh) 2015-11-06
CA2734535C (en) 2018-08-28
CA3011730C (en) 2022-05-17
HRP20160127T1 (hr) 2016-03-11
SI2340506T1 (sl) 2016-02-29
CN104198709A (zh) 2014-12-10
EP2340506B1 (en) 2015-11-11
CN102209968A (zh) 2011-10-05
AU2015249113A1 (en) 2015-11-12
DK2340506T3 (en) 2016-02-08
JP2012502281A (ja) 2012-01-26
AU2009291811A1 (en) 2010-03-18
KR20110063753A (ko) 2011-06-14
CA2734535A1 (en) 2010-03-18
HK1153834A1 (en) 2012-04-05
JP5701212B2 (ja) 2015-04-15
ES2559758T3 (es) 2016-02-15
EP2340506A4 (en) 2012-02-15
GB2478441A (en) 2011-09-07
AU2009291811B2 (en) 2015-10-29
EP2340506A1 (en) 2011-07-06
CN102209968B (zh) 2016-05-04
CA3152591A1 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
GB2478441B (en) Lung cancer biomarkers and uses thereof
IL269454B (en) Qualitative losses and their uses
IL223295A0 (en) Lung cancer biomarkers and uses thereof
GB0719792D0 (en) Cancer biomarkers
IL252163A0 (en) Lung cancer biomarkers and their uses
IL202727A0 (en) Covalent diabodies and uses thereof
SG10201710447QA (en) Pancreatic cancer biomarkers and uses thereof
GB0818660D0 (en) Biomarkers
EP2350917A4 (en) BIOMARKERS OF OVARIAN CANCER AND USES THEREOF
GB0807214D0 (en) Biomarkers
GB0719527D0 (en) Value determination
GB0616230D0 (en) Biomarkers and uses thereof
GB0821912D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers
HK1178251A (en) Lung cancer biomarkers and uses thereof
GB0720334D0 (en) Cancer biomarker
AU2009900954A0 (en) Cancer Biomarkers and Uses Therefor
GB0809105D0 (en) Biomarkers
GB0805081D0 (en) Biomarkers
GB0805084D0 (en) Biomarkers
GB0708064D0 (en) Biomarker